National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 673432

Case Details

VAERS ID: 673432 (history)  
Age:   
Gender: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-09
Entered: 2016-09-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Amnesia, Arthritis, Death, Epilepsy, Headache, Myalgia, Myocardial infarction
SMQs:, Rhabdomyolysis/myopathy (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Dementia (broad), Convulsions (narrow), Embolic and thrombotic events, arterial (narrow), Noninfectious encephalopathy/delirium (broad), Eosinophilic pneumonia (broad), Generalised convulsive seizures following immunisation (narrow), Arthritis (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? Yes
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1609VNM003100

Write-up: This solicited report was received from a social media researcher regarding an article about female patients who received HPV vaccine. The patient numbers were unknown. The patients'' concurrent conditions, medical history and concomitant medications were not reported. On an unknown date/dates the patient/patients received GARDASIL (dosing details not specified). The article indicated that patients had dangerous side effects (myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache and death) after receiving GARDASIL vaccine (the onset date was also reported as 07-JUL-2016). The article also indicated the that the vaccine''s effect was not verified and could increase the risk of getting cervical cancer. The action taken with GARDASIL due to the events was reported as unknown. The outcome of the events myocardial infarction, headache, epilepsy, memory loss, arthritis, increased risk of cervical cancer and muscle ache was unknown. The causal relationship between the events myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache, increased risk of cervical cancer and death with GARDASIL was unknown. Events myocardial infarction, headache, epilepsy, memory loss, arthritis, muscle ache, increased risk of cervical cancer and death with were considered medically significant. The event myocardial infarction was considered life threatening. The events headache, epilepsy, myocardial infarction, memory loss, arthritis, muscle ache were considered to causing disability. Additional information is not expected as there was not consent for contact.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=673432


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166